Marcela Belleza e Letícia Angoleri convidam Aline Campos para conversar sobre atualizações do GINA 2024 na abordagem da asma ambulatorial.

Quer saber mais sobre asma? Acesso o Guia TdC: https://www.tadeclinicagem.com.br/guia/368/atualizacao-de-asma-gina-2024/

Referências:
1. https://www.tadeclinicagem.com.br/guia/368/atualizacao-de-asma-gina-2024/
2. https://www.tadeclinicagem.com.br/guia/174/asma-gina-2023/
3. https://ginasthma.org/2024-report/
4. Stanojevic, Sanja et al. “ERS/ATS technical standard on interpretive strategies for routine lung function tests.” The European respiratory journal vol. 60,1 2101499. 13 Jul. 2022, doi:10.1183/13993003.01499-2021
5. Albuquerque AL, Berton DC, Campos EV, Queiroga-Júnior FJ, Santana AN, Wong BD, Batista DR, Melo FX, Didier-Neto FM, Barros JA, Salge JM. Novas recomendações de espirometria da Sociedade Brasileira de Pneumologia e Tisiologia-atualização 2024. Jornal Brasileiro de Pneumologia. 2025 Jan 20;50:e20240169. https://dx.doi.org/10.36416/1806-3756/e2021027
6. Rank, Matthew A et al. “The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials.” The Journal of allergy and clinical immunology vol. 131,3 (2013): 724-9. doi:10.1016/j.jaci.2012.11.038
7. Grant, Torie et al. “Asthma and the social determinants of health.” Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 128,1 (2022): 5-11. doi:10.1016/j.anai.2021.10.002
8. https://www.nice.org.uk/guidance/ng80/chapter/recommendations#algorithms
9. O'Byrne, Paul M et al. “Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.” The New England journal of medicine vol. 378,20 (2018): 1865-1876. doi:10.1056/NEJMoa1715274
9. Bateman, Eric D et al. “As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.” The New England journal of medicine vol. 378,20 (2018): 1877-1887. doi:10.1056/NEJMoa1715275
10. Melani, Andrea S et al. “Inhaler mishandling remains common in real life and is associated with reduced disease control.” Respiratory medicine vol. 105,6 (2011): 930-8. doi:10.1016/j.rmed.2011.01.005
11. Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896-902. doi:10.1016/j.jaci.2014.08.042